Suppr超能文献

相似文献

3
SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome.
Hum Genet. 2004 May;114(6):553-61. doi: 10.1007/s00439-004-1104-z. Epub 2004 Mar 10.
4
Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region.
Dev Biol. 2005 Oct 15;286(2):587-600. doi: 10.1016/j.ydbio.2005.07.030. Epub 2005 Aug 29.
5
Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.
Hum Mol Genet. 2012 Jul 1;21(13):3001-12. doi: 10.1093/hmg/dds130. Epub 2012 Apr 5.
6
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13938-43. doi: 10.1073/pnas.1305426110. Epub 2013 Aug 5.
7
Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
Nucleic Acids Res. 2005 Jul 18;33(13):3976-84. doi: 10.1093/nar/gki705. Print 2005.
9
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Nature. 2015 Feb 19;518(7539):409-12. doi: 10.1038/nature13975. Epub 2014 Dec 1.
10
Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus.
Nucleic Acids Res. 2005 Aug 22;33(15):4740-53. doi: 10.1093/nar/gki786. Print 2005.

引用本文的文献

1
AAV-dCas9 vector unsilences paternal Ube3a in neurons by impeding Ube3a-ATS transcription.
Commun Biol. 2025 Sep 2;8(1):1332. doi: 10.1038/s42003-025-08794-2.
2
Activation of the imprinted Prader-Willi syndrome locus by CRISPR-based epigenome editing.
Cell Genom. 2025 Feb 12;5(2):100770. doi: 10.1016/j.xgen.2025.100770.
4
Roles of SNORD115 and SNORD116 ncRNA clusters during neuronal differentiation.
Nat Commun. 2024 Nov 30;15(1):10427. doi: 10.1038/s41467-024-54573-8.
5
Generation of isogenic models of Angelman syndrome and Prader-Willi syndrome in CRISPR/Cas9-engineered human embryonic stem cells.
PLoS One. 2024 Nov 1;19(11):e0311565. doi: 10.1371/journal.pone.0311565. eCollection 2024.
6
Exploring the Frontier: Antisense Long Non-Coding RNAs as Key Regulators in Alzheimer's Disease.
Aging Dis. 2024 Aug 19;16(4):1793-1812. doi: 10.14336/AD.2024.0762.
9
Ube3a unsilencer for the potential treatment of Angelman syndrome.
Nat Commun. 2024 Jul 8;15(1):5558. doi: 10.1038/s41467-024-49788-8.
10
Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome.
Mol Ther. 2024 Aug 7;32(8):2662-2675. doi: 10.1016/j.ymthe.2024.05.034. Epub 2024 May 24.

本文引用的文献

1
SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome.
Hum Genet. 2004 May;114(6):553-61. doi: 10.1007/s00439-004-1104-z. Epub 2004 Mar 10.
2
Control elements within the PWS/AS imprinting box and their function in the imprinting process.
Hum Mol Genet. 2004 Apr 1;13(7):751-62. doi: 10.1093/hmg/ddh085. Epub 2004 Feb 12.
3
4
5
The imprinting mechanism of the Prader-Willi/Angelman regional control center.
EMBO J. 2002 Nov 1;21(21):5807-14. doi: 10.1093/emboj/cdf570.
10
Angelman syndrome: mimicking conditions and phenotypes.
Am J Med Genet. 2001 Jun 1;101(1):59-64. doi: 10.1002/ajmg.1316.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验